A regular Meeting of Shareholders of Farmak JSC was held on March 19, 2014.
Director General of Farmak JSC, Filya Zhebrovska, spoke at the meeting of the participants reporting on the Company’s activities in the year 2013 and covering the main development activities of Farmak JSC for the year 2014.
The Chairman of Supervisory Board, Pavlo Zebrivsky, in his speech highly appreciated the Company’s activities in the year 2013. Viktoria Smarodina, Chief Financial Officer, and Dmytro Taranchuk, Head of Legal Department, also reported on the issues on the meeting agenda.
All the issues on the agenda of a regular Meeting of Shareholders of Farmak JSC have been determined.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...